Alireza Ghoreifi, MD
Alireza Ghoreifi, MD, is a urologic oncologist and Assistant Professor of Clinical Urology at the University of California, Irvine (UCI). He specializes in the surgical management of genitourinary malignancies. His clinical interests include bladder, kidney, upper tract urothelial, prostate, and testicular cancers, with expertise in both open and robotic surgery.
Dr. Ghoreifi completed his urology residency at Mashhad University of Medical Sciences in Iran, where he also served as an Assistant Professor of Urology for four years. He subsequently completed advanced research training in urologic oncology at the University of Southern California (USC) Institute of Urology, followed by a Society of Urologic Oncology (SUO) fellowship at Duke University. He joined the UCI Department of Urology in September 2026.
Dr. Ghoreifi’s research focuses on improving the diagnosis, treatment, and outcomes of patients with urologic cancers. His work encompasses clinical trials, multicenter collaborative studies, biomarker development, and surgical innovation, with particular interests in bladder cancer, upper tract urothelial carcinoma, testicular cancer, and advanced renal cell carcinoma. He has authored more than 145 peer-reviewed publications and has presented his research at numerous national and international scientific meetings.
His research has been recognized with several prestigious awards, including the Urology Care Foundation Research Scholar Award, the American Urological Association (AUA) Best Poster Award, and the Western Section of the AUA Grand Prize Award. He also serves as a reviewer for several leading urologic journals and actively participates in national and international collaborative research initiatives.
Dr. Ghoreifi is committed to delivering compassionate, evidence-based, and personalized care while advancing the field of urologic oncology through research, innovation, and education.
Areas of focus:
- Urologic oncology (bladder, UTUC, kidney, prostate, testicular, and penile cancers)
- Open and robotic urologic oncology surgery
- Complex urothelial cancer management, including radical cystectomy, bladder-sparing approaches, and upper tract urothelial carcinoma
- Testicular cancer surgery, including retroperitoneal lymph node dissection
- Clinical trials and translational research, including novel cancer biomarkers
Medical School: Hormozgan University of Medical Sciences
Internship: Hormozgan University of Medical Sciences
Residency: Imam Reza Hospital, Mashhad University of Medical Sciences
Research Fellowship: University of Southern California
Fellowship Training: Duke University
Honors and Awards
May 2026 — Featured SUO Fellow, Urologic Oncology Journal
March 2026 — Urology Scientific Mentoring and Research Training (USMART) Program, American Urological Association
March 2026 — Best Podium Presentation, Renal Cell Carcinoma (First Author), SESAUA
January 2026 — Outstanding Early Career Editorial Board Member, Current Urology Journal
January 2026 — Best Reviewer Award (2024–2025), Current Urology Journal
August 2025 — Scientific Merit and Travel Award, World Conference on Genitourinary Cancers
May 2025 — Top Reviewer Award (2024), The Journal of Urology
March 2025 — Travel Award, GU Oncology Early Career Thought Leaders Conference
June 2024 — AUA Research Scholar Award, Urology Care Foundation
December 2023 — Best Reviewer Award, SIU Journal
December 2023 — Best Reviewer Award, Current Urology Journal
October 2023 — Grand Prize, Best Poster Presentation (Co-author), WSAUA
May 2023 — Best Poster Presentation, Urinary Diversion (Presenting Author), AUA
November 2022 — Grand Prize, Best Poster Presentation (First Author), WSAUA
November 2022 — Miley & Wesson Resident Essay Competition (Third Place), WSAUA
November 2022 — Scholarship Award, WSAUA
November 2021 — Scholarship Award, WSAUA
November 2019 — Best Poster Presentation (Third Place), WSAUA
April 2018 — UAA Youth Section Scholarship Award, Urological Association of Asia
May 2016 — Scholarship Award, Selected Nominee to Represent the Urological Association of Asia at the 5th International Forum on Frontiers in Urology (IFFU)